We are live on
!
Find out more
EI
EAM Investors Portfolio holdings
AUM
$866M
1-Year Est. Return
377.14%
This Fund
S&P 500
This Quarter
Est. Return
+24.71%
1 Year Est. Return
+377.14%
3 Year Est. Return
+5,228.32%
5 Year Est. Return
+49,813.17%
10 Year Est. Return
+19,957,666.26%
AUM
$866M
AUM Growth
+$149M
(+21%)
Cap. Flow
+$43.9M
Cap. Flow
% of AUM
5.07%
Top 10 Holdings %
Top 10 Hldgs %
7.14%
Holding
453
New
147
Increased
91
Reduced
74
Closed
130
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CSII
Cardiovascular Systems, Inc.
CSII
|
+$4.71M |
| 2 |
GIMO
Gigamon Inc.
GIMO
|
+$4.45M |
| 3 |
EGRX
Eagle Pharmaceuticals, Inc.
EGRX
|
+$4.39M |
| 4 |
SAAS
inContact, Inc.
SAAS
|
+$4.38M |
| 5 |
INN
Summit Hotel Properties
INN
|
+$4.32M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ESPR
Esperion Therapeutics
ESPR
|
+$6.11M |
| 2 |
IMPV
Imperva, Inc.
IMPV
|
+$5.46M |
| 3 |
RadNet
RDNT
|
+$5.41M |
| 4 |
PLNR
PLANAR SYSTEMS INC
PLNR
|
+$4.97M |
| 5 |
Motorcar Parts of America
MPAA
|
+$4.78M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.59% |
| 2 | Technology | 18.66% |
| 3 | Consumer Discretionary | 13.65% |
| 4 | Industrials | 11.89% |
| 5 | Communication Services | 5.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ESPR
1
DELISTED
Esperion Therapeutics
ESPR
| $8.27M | 0.96% |
89,335
-94,685
| -51% | -$6.11M |
|
|
FOLD
2
DELISTED
Amicus Therapeutics
FOLD
| $6.81M | 0.79% |
625,694
-164,146
| -21% | -$1.45M |
|
|
EGRX
3
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $6.48M | 0.75% |
+154,734
| New | +$4.39M |
|
|
USCR
4
DELISTED
U S Concrete, Inc.
USCR
| $6.43M | 0.74% |
189,758
+55,505
| +41% | +$1.64M |
|
5
TG Therapeutics
TGTX
$8.58B
| $6.22M | 0.72% |
401,875
-28,752
| -7% | -$435K |
|
6
Covenant Logistics
CVLG
$1.18B
| $5.72M | 0.66% |
344,736
+180,386
| +110% | +$2.74M |
|
7
Patrick Industries
PATK
$2.8B
| $5.63M | 0.65% |
305,249
+131,025
| +75% | +$1.98M |
|
|
CBM
8
DELISTED
Cambrex Corporation
CBM
| $5.5M | 0.64% |
+138,853
| New | +$4.11M |
|
|
TDAY
9
USA Today Co
TDAY
$1.23B
| $5.45M | 0.63% |
227,767
+33,418
| +17% | +$776K |
|
|
CSII
10
DELISTED
Cardiovascular Systems, Inc.
CSII
| $5.34M | 0.62% |
+136,844
| New | +$4.71M |
|
|
RCPT
11
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
| $5.29M | 0.61% |
32,082
-23,245
| -42% | -$2.94M |
|
|
BLUE
12
DELISTED
bluebird bio
BLUE
| $5.28M | 0.61% |
3,374
-1,380
| -29% | -$1.82M |
|
13
OneMain Financial
OMF
$6.9B
| $5.23M | 0.6% |
101,061
+29,748
| +42% | +$1.2M |
|
|
TWOU
14
DELISTED
2U Inc
TWOU
| $5.22M | 0.6% |
6,808
+254
| +4% | +$145K |
|
15
LendingTree
TREE
$544M
| $5.2M | 0.6% |
92,748
+12,790
| +16% | +$610K |
|
|
RALY
16
DELISTED
RALLY SOFTWARE DEV CORP
RALY
| $5.05M | 0.58% |
+321,577
| New | +$3.94M |
|
17
VanEck India Growth Leaders ETF
GLIN
$93.7M
| $4.99M | 0.58% |
105,653
+246
| +0.2% | +$11.7K |
|
18
Coherus Oncology
CHRS
$217M
| $4.97M | 0.57% |
+162,485
| New | +$4.2M |
|
19
Kadant
KAI
$3.69B
| $4.95M | 0.57% |
+94,103
| New | +$4.16M |
|
|
GIMO
20
DELISTED
Gigamon Inc.
GIMO
| $4.89M | 0.56% |
+230,260
| New | +$4.45M |
|
|
NVRO
21
DELISTED
NEVRO CORP.
NVRO
| $4.88M | 0.56% |
101,739
+72,575
| +249% | +$3.15M |
|
|
LDRH
22
DELISTED
LDR HOLDINGS CORP COM STK
LDRH
| $4.86M | 0.56% |
132,716
+1,024
| +0.8% | +$37.2K |
|
|
ASRT
23
DELISTED
Assertio
ASRT
| $4.84M | 0.56% |
3,601
-319
| -8% | -$393K |
|
24
AMN Healthcare
AMN
$1.28B
| $4.8M | 0.55% |
207,946
+145,014
| +230% | +$3M |
|
|
BLOX
25
DELISTED
Infoblox Inc
BLOX
| $4.75M | 0.55% |
199,173
+136,530
| +218% | +$2.93M |
|
Similar funds
NEPWA
RWM
MCM
HP
OMG
RB
BGC
ICCFIA
EAM Investors's Q1 2015 Portfolio in Review
As of Q1 2015, EAM Investors held 453 positions worth $866M, up 21% from $717M the previous quarter. Its ten largest holdings account for 7.1% of the portfolio.
EAM Investors deployed $43.9M of net new capital in Q1 2015, opening 147 new positions and adding to 91 existing holdings. Its largest new stake was Cardiovascular Systems, Inc.: 136,844 shares worth $5.34M.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 27% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Esperion Therapeutics, an estimated $6.11M trimmed.
- EAM Investors's largest Q1 2015 buy was Cardiovascular Systems, Inc.: 136,844 shares worth $5.34M.
- EAM Investors added most to NEVRO CORP. in Q1 2015, an estimated $3.15M increase.
- EAM Investors's biggest Q1 2015 reduction was Esperion Therapeutics, cutting an estimated $6.11M.
- EAM Investors fully exited Imperva, Inc. in Q1 2015, selling an estimated $5.46M.
- EAM Investors's ten largest holdings make up 7.1% of its $866M portfolio in Q1 2015.
- EAM Investors opened 147 new positions and closed 130 in Q1 2015.
- EAM Investors's portfolio value rose 21% quarter-over-quarter to $866M.
Based on EAM Investors's 13F filing for Q1 2015, filed 7 May 2015.